BIOA Stock Analysis: Buy, Sell, or Hold?
BIOA - BioAge Labs, Inc. Common Stock
$17.44
-0.62 (-3.43%)
▼
5d:
-11.07%
30d:
+7.99%
90d:
-11.02%
WAIT
LOW Confidence
Analysis Updated: Apr 28, 2026 12:00 AM ET
Earnings: May 05, 2026
5d
Get Alerted When BIOA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: BIOA is down 11.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: BIOA is down 11.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: BIOA is currently trading at $17.44, which is considered fair relative to its 30-day fair value range of $16.39 to $18.30.
Technical Outlook: Technically, BIOA is in a uptrend. Immediate support is located at $16.30, while resistance sits at $20.36. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: BIOA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $53.33 (+205.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BIOA is in a uptrend. Immediate support is located at $16.30, while resistance sits at $20.36. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: BIOA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $53.33 (+205.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$16.39 -
$18.30
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
81.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.4%)
- BULLISH: Trading 205.8% below Wall St target ($53.33)
- WARNING: Recommendation downgraded due to -11.1% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$16.39 -
$18.30
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$16.30
Resistance Level
$20.36
Current Trend
Uptrend
Technical data as of
Apr 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.28
Wall Street Target
$53.33
(+205.8%)
Share & Embed Analysis
Last updated: April 29, 2026 4:09 AM ET
Data refreshes hourly during market hours. Next update: 5:09 AM
Data refreshes hourly during market hours. Next update: 5:09 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BIOA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Paul D Rubin
SELL
7433 shares
2026-02-02
Dov A Md Goldstein
SELL
27000 shares
2026-01-13
Kristen Fortney
SELL
233107 shares
2026-01-13
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$186 | 60 HOLD |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$150 | 59 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$94 | 58 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 58 HOLD |
|
AVDL
Avadel Pharmaceuticals P… |
STRONG BUY
8 analysts |
$21 | 62 BUY |
